CNBC's Mandy Drury looks ahead to what are likely to be next week's top business and financial stories.» Read More
Roger Tan, CEO of Voyage Research, says the slump in the commodity sector is hurting Singapore-listed Noble Group more than its accounting and management practices.
Macrae Sykes, research analyst at Gabelli & Company, explains why Berkshire Hathaway's acquisition of Precision Castparts is a "fairly rational" move.
Jim Awad, managing director of Plimsoll Mark Capital, discusses news that Warren Buffett's Berkshire Hathaway has agreed to buy aerospace and energy equipment maker Precision Castparts.
Alibaba making a $4.6 billion investment in Chinese electronics retailer Suning.
Mallinckrodt said it would buy immunotherapy company Therakos in a deal valued at about $1.33 billion.
"This takes us out of the market for an elephant," Warren Buffett tells CNBC about the $37.2 billion deal for Precision Castparts.
Berkshire Hathaway reportedly nears a $30 billion deal for Precision Castparts.
James West, senior healthcare analyst for Results Healthcare, discusses how to profit from the surge in healthcare mergers and acquisitions.
James West, senior healthcare analyst for Results Healthcare, explains why there has been so much activity in healthcare and pharma M&A.
Berkshire Hathaway, the conglomerate owned by Warren Buffett, is close to a deal that may be its largest ever, the WSJ reported.
CNBC's Dominic Chu looks ahead to what are likely to be next week's top business and financial stories.
Symetra has been exploring the possibility of selling itself in recent months, according to people familiar with the matter.
A crackdown to stop U.S. businesses pursuing takeovers to avoid tax was dealt a rebuke following two deals, the FT report.
CF Industries on Thursday announced it has agreed to merge with OCI in a deal valued at approximately $8 billion, including about $2 billion in debt.
Nick Hungerford, CEO of Nutmeg, discusses Zurich Insurance, which may be considering a takeover bid on British insurer RSA.
Martin Senn, CEO of Zurich Insurance, discusses his company, which is considering a takeover bid for British insurer RSA.
Marcus Kuhnert, CFO of Merck Group, discusses his company's earnings, sales growth strategy and acqusitions
Blair Effron, Centerview Partners, joins CNBC's David Faber to discuss merger and acquisition activity at a record high.
Gavin Wendt, founding director & senior resource analyst at MineLife, discusses news that China's state-owned companies have approached Fortescue Metals to buy a stake in the latter's infrastructure assets.
Aetna Chairman and CEO Mark Bertolini, discusses the company's decision to raise its guidance for the year, competition in the Medicare space and the Humana deal.